quantisnow
FeedTopReportsPricing
⌘K
Live feed
07:01:00·46d
PRRelease
Precision BioSciences Inc. logo

Precision BioSciences Receives FDA Fast Track Designation for PBGENE-DMD and Announces Duchenne Muscular Dystrophy Investor Event

DTIL· Precision BioSciences Inc.
Health Care
Original source

Companies

  • DTIL
    Precision BioSciences Inc.
    Health Care

Recent analyst ratings

  • Jan 10UpdateBMO Capital Markets$34.00
  • Apr 30UpdateGuggenheim$19.00
  • Jun 17UpdateBMO Capital Markets$7.00
  • Jun 9UpdateWilliam Blair-
  • Sep 10UpdateStifel$26.00

Related

  • PR2h
    Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
  • SEC16d
    SEC Form DEFA14A filed by Precision BioSciences Inc.
  • SEC16d
    SEC Form DEF 14A filed by Precision BioSciences Inc.
  • PR16d
    Precision BioSciences to Participate in the 25th Annual Needham Virtual Healthcare Conference
  • SEC27d
    SEC Form PRE 14A filed by Precision BioSciences Inc.
  • PR37d
    iECURE Selected for U.S. FDA Chemistry, Manufacturing, and Controls Development and Readiness Pilot Program to Support Manufacturing Readiness of ECUR-506 Ahead of Planned BLA Submission
  • SEC38d
    Precision BioSciences Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
  • SEC43d
    SEC Form 10-K filed by Precision BioSciences Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022